Pablo J Aschner

Summary

Affiliation: School of Dentistry
Country: Colombia

Publications

  1. ncbi request reprint Diabetes trends in Latin America
    Pablo Aschner
    Endocrine Unit, Javeriana University, Scientific Subdirector, Diabetes Center, Colombian Diabetes Association, Colombia
    Diabetes Metab Res Rev 18:S27-31. 2002
  2. doi request reprint Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America
    Pablo Aschner
    Javeriana University School of Medicine, Bogota, Colombia
    J Clin Hypertens (Greenwich) 11:769-74. 2009
  3. doi request reprint Diabetes in South and Central America: An update
    Pablo Aschner
    Javeriana University School of Medicine and San Ignacio University Hospital, Bogota, Colombia Electronic address
    Diabetes Res Clin Pract 103:238-43. 2014
  4. doi request reprint Metabolic memory for vascular disease in diabetes
    Pablo J Aschner
    Javeriana Pontificia University, San Ignacio University Hospital, Bogota, Colombia
    Diabetes Technol Ther 14:S68-74. 2012
  5. doi request reprint Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial
    Pablo Aschner
    Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogota, Colombia
    Lancet 379:2262-9. 2012
  6. pmc Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study
    Rodolfo J Dennis
    Department of Research, Fundación CardioInfantil Instituto de Cardiología, Bogota, Colombia
    BMC Pulm Med 10:38. 2010
  7. doi request reprint Metabolic syndrome as a risk factor for diabetes
    Pablo Aschner
    Javeriana University, Avenida 15, Bogota, Colombia
    Expert Rev Cardiovasc Ther 8:407-12. 2010
  8. pmc The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
    Pablo J Aschner
    Javeriana University, Avenida 15 No 124 47 Of 409, Bogota, Colombia
    Diabetol Metab Syndr 2:69. 2010
  9. doi request reprint Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women
    Pablo Aschner
    Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogota, Colombia
    Diabetes Res Clin Pract 93:243-7. 2011
  10. doi request reprint [IDEA study (International Day for the Evaluation of Abdominal Obesity): primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia]
    Alvaro J Ruiz
    Departamento de Epidemiología Clínica y Bioestadística, Facultad de Medicina, Pontificia Universidad Javeriana, Bogota, D C, Colombia
    Biomedica 32:610-6. 2012

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Diabetes trends in Latin America
    Pablo Aschner
    Endocrine Unit, Javeriana University, Scientific Subdirector, Diabetes Center, Colombian Diabetes Association, Colombia
    Diabetes Metab Res Rev 18:S27-31. 2002
    ..Hospital costs account for most direct expenditures associated with treatment, and mortality associated with diabetes has increased markedly in some areas over the past 2 decades...
  2. doi request reprint Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America
    Pablo Aschner
    Javeriana University School of Medicine, Bogota, Colombia
    J Clin Hypertens (Greenwich) 11:769-74. 2009
    ..Strikingly, abdominal adiposity was very frequent in women with normal body mass index, suggesting that an evidence-based definition of abdominal adiposity in Latin America is needed...
  3. doi request reprint Diabetes in South and Central America: An update
    Pablo Aschner
    Javeriana University School of Medicine and San Ignacio University Hospital, Bogota, Colombia Electronic address
    Diabetes Res Clin Pract 103:238-43. 2014
    ..The available epidemiological data provide the background to act in developing national diabetes programmes which integrate diabetes care with cardiovascular prevention and promote diabetes prevention as well. ..
  4. doi request reprint Metabolic memory for vascular disease in diabetes
    Pablo J Aschner
    Javeriana Pontificia University, San Ignacio University Hospital, Bogota, Colombia
    Diabetes Technol Ther 14:S68-74. 2012
    ....
  5. doi request reprint Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial
    Pablo Aschner
    Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogota, Colombia
    Lancet 379:2262-9. 2012
    ..We aimed to compare the efficacy, tolerability, and safety of insulin glargine and sitagliptin, a DPP-4 inhibitor, in patients whose disease was uncontrolled with metformin...
  6. pmc Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study
    Rodolfo J Dennis
    Department of Research, Fundación CardioInfantil Instituto de Cardiología, Bogota, Colombia
    BMC Pulm Med 10:38. 2010
    ..We evaluated if lung function is worse in patients with inadequate glucose control, and if inflammatory markers are simultaneously increased in these subjects...
  7. doi request reprint Metabolic syndrome as a risk factor for diabetes
    Pablo Aschner
    Javeriana University, Avenida 15, Bogota, Colombia
    Expert Rev Cardiovasc Ther 8:407-12. 2010
    ..Some fibrates have reduced or delayed incident diabetes. Extended-release niacin has a neutral effect and statins are controversial. ACE inhibitors and ARBs are the antihypertensive agents least associated with incident diabetes...
  8. pmc The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
    Pablo J Aschner
    Javeriana University, Avenida 15 No 124 47 Of 409, Bogota, Colombia
    Diabetol Metab Syndr 2:69. 2010
    ....
  9. doi request reprint Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women
    Pablo Aschner
    Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogota, Colombia
    Diabetes Res Clin Pract 93:243-7. 2011
    ..We tested WC as a diagnostic tool to identify people with visceral adiposity in Hispanics from the Latin America region...
  10. doi request reprint [IDEA study (International Day for the Evaluation of Abdominal Obesity): primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia]
    Alvaro J Ruiz
    Departamento de Epidemiología Clínica y Bioestadística, Facultad de Medicina, Pontificia Universidad Javeriana, Bogota, D C, Colombia
    Biomedica 32:610-6. 2012
    ..A less predictive alternate measurement is known as the body mass index (BMI)...
  11. ncbi request reprint Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    Pablo Aschner
    Colombian Diabetes Association, Bogota, Colombia
    Diabetes Care 29:2632-7. 2006
    ..To examine the efficacy and safety of once-daily oral sitagliptin as monotherapy in patients with type 2 diabetes...
  12. ncbi request reprint Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials
    Avraham Karasik
    Chaim Sheba Medical Center, Tel Hashomer, Israel
    Curr Med Res Opin 24:489-96. 2008
    ..There are numerous DPP-4 inhibitors in development with sitagliptin as the first approved agent for the treatment of patients with type 2 diabetes...
  13. ncbi request reprint Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride
    Freddy G Eliaschewitz
    Hospital Heliopolis, Sao Paulo, Brazil
    Arch Med Res 37:495-501. 2006
    ..This study compared the efficacy and safety of insulin glargine and NPH insulin, both in combination with a once-daily fixed dose of glimepiride, in terms of glycemic control and incidence of hypoglycemia...